Rating date
Jul 20, 2026
21 days ago
CMCSA Equity Research — OVERWEIGHT — July 2026
Rating date
Jul 20, 2026
21 days ago
Desk view
OW
5D move
—
Awaiting market data
Peer rank
43p
Research history
2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 moreInvestment card · CMCSA
Now I have all the data I need. Here is the analysis:
Desk rating
OW
Tactical OW · 12M OW
Horizon
Long-term
Confidence
Medium
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Bias
OVERWEIGHT
Catalysts
Risks
Price context alongside the research narrative.
Full desk note for Jul 20, 2026. Use tabs for catalysts, valuation and risks, or open the full note.
WebserviceX · Agentic Research Desk
CMCSA bias
OVERWEIGHT
Horizon
Long-term
CMCSA key risk
Event-driven repricing risk if expectations diverge from incoming evidence.
CMCSA catalyst watch
CMCSA is in a clear long-term downtrend with price well below the declining 200-day SMA; the death cross between the 50- and 200-day SMAs reinforces this.
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Confidence
Medium
How the call aged · 5D
Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-21T15:52:19.829202+00:00.
5D move
—
2026-07-20 → awaiting
Outcome
Awaiting market data
5D trend
-0.79%
Vol (20D ann.)
+28.04%
vs SPY: +0.15%
Close 23.78 → — (USD, vendor closes)
Batch scorecard · 2026-07-20 · CMCSA
Publish QC
Pipeline fingerprint 2f45a102687f75c0
Trace a3dc3d2a…
No QC issues recorded.